Correlation Between GlaxoSmithKline PLC and Vy Goldman
Can any of the company-specific risk be diversified away by investing in both GlaxoSmithKline PLC and Vy Goldman at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining GlaxoSmithKline PLC and Vy Goldman into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between GlaxoSmithKline PLC ADR and Vy Goldman Sachs, you can compare the effects of market volatilities on GlaxoSmithKline PLC and Vy Goldman and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in GlaxoSmithKline PLC with a short position of Vy Goldman. Check out your portfolio center. Please also check ongoing floating volatility patterns of GlaxoSmithKline PLC and Vy Goldman.
Diversification Opportunities for GlaxoSmithKline PLC and Vy Goldman
0.84 | Correlation Coefficient |
Very poor diversification
The 3 months correlation between GlaxoSmithKline and VGSBX is 0.84. Overlapping area represents the amount of risk that can be diversified away by holding GlaxoSmithKline PLC ADR and Vy Goldman Sachs in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Vy Goldman Sachs and GlaxoSmithKline PLC is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on GlaxoSmithKline PLC ADR are associated (or correlated) with Vy Goldman. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Vy Goldman Sachs has no effect on the direction of GlaxoSmithKline PLC i.e., GlaxoSmithKline PLC and Vy Goldman go up and down completely randomly.
Pair Corralation between GlaxoSmithKline PLC and Vy Goldman
Considering the 90-day investment horizon GlaxoSmithKline PLC ADR is expected to generate 2.09 times more return on investment than Vy Goldman. However, GlaxoSmithKline PLC is 2.09 times more volatile than Vy Goldman Sachs. It trades about 0.01 of its potential returns per unit of risk. Vy Goldman Sachs is currently generating about 0.01 per unit of risk. If you would invest 3,251 in GlaxoSmithKline PLC ADR on August 24, 2024 and sell it today you would earn a total of 119.00 from holding GlaxoSmithKline PLC ADR or generate 3.66% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Strong |
| Accuracy | 100.0% |
| Values | Daily Returns |
GlaxoSmithKline PLC ADR vs. Vy Goldman Sachs
Performance |
| Timeline |
| GlaxoSmithKline PLC ADR |
| Vy Goldman Sachs |
GlaxoSmithKline PLC and Vy Goldman Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with GlaxoSmithKline PLC and Vy Goldman
The main advantage of trading using opposite GlaxoSmithKline PLC and Vy Goldman positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if GlaxoSmithKline PLC position performs unexpectedly, Vy Goldman can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Vy Goldman will offset losses from the drop in Vy Goldman's long position.| GlaxoSmithKline PLC vs. Novartis AG ADR | GlaxoSmithKline PLC vs. AstraZeneca PLC ADR | GlaxoSmithKline PLC vs. Roche Holding Ltd | GlaxoSmithKline PLC vs. Bristol Myers Squibb |
| Vy Goldman vs. Falcon Focus Scv | Vy Goldman vs. Rbc Microcap Value | Vy Goldman vs. Volumetric Fund Volumetric | Vy Goldman vs. Arrow Managed Futures |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.
Other Complementary Tools
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine |